Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 July 2024 | Story Lunga Luthuli | Photo Suplied
IABC Awards 2024
The UFS HR Division celebrates its win at the 2024 IABC Gold Quill Awards for its 2023 UFS Women’s Breakfast.

The University of the Free State's (UFS’s) Human Resources Division has been awarded gold in the Special and Experiential Events Category at the 2024 International Association of Business Communicators (IABC) Gold Quill Awards held in Chicago, Illinois. This accolade recognises the division’s exceptional work on the 2023 UFS Women’s Breakfast, an event that exemplified innovative communication and organisational development.

"Winning the gold at the 2024 IABC Gold Quill Awards is a significant honour for both the Human Resources Division and the UFS," said Susan van Jaarsveld, Senior Director of the HR Division. "This recognition highlights our commitment to excellence and innovation in communication and organisational development. It validates the hard work and dedication of our team in fostering a positive workplace culture and enhancing employee engagement and well-being."

The 2023 UFS Women’s Breakfast was meticulously planned, and executed with a unique ‘journey’ theme. "Since we have just launched our onboarding programme based on a journey theme, we extended this theme to our Women’s Breakfast," van Jaarsveld explained. "A carefully curated communication strategy and plan guided our actions, and we invited guests to ‘board a flight’ with us, integrating the journey theme with our content. Our approach is neatly tied into the UFS’s Vision 130, which is a journey to a better destination."

The primary objectives of the event were to promote the UFS's Vision 130, and to increase participation in university initiatives. "Data collected after the event indicated that we did hit the mark," van Jaarsveld noted. "Guests felt more familiar with the UFS’s Vision 130, and also experienced a sense of inclusion. Participation in our initiatives increased significantly – in some cases by 200%. Our biggest problem this year is finding venues that can accommodate our growing numbers."

The success of the UFS Women’s Breakfast was attributed to several innovative elements, including a video invitation simulating an airport boarding call, and staff dressed as flight attendants. "Some attendees thought our team was hired from a professional airline – what a compliment to the UFS Organisational Development team!" van Jaarsveld remarked.

Van Jaarsveld emphasised the importance of such events for fostering community and engagement within the university. "Studies have shown that positive social events in the workplace improve employee engagement and satisfaction," she said. "It is important for employees to see and feel that they are valued, and that their well-being is a priority."

Looking ahead, the HR Division plans to continue creating impactful and award-winning events. "Teamwork makes dream-work! Our goal is to 'be better' – not just about achieving external recognition or awards, but about making a meaningful and lasting impact on the university community we serve," van Jaarsveld concluded.

The UFS Human Resources Division’s dedication, perseverance, and award-winning efforts demonstrate its innovative and engaging initiatives, setting a high standard for future events and reinforcing the university's commitment to excellence.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept